In a transaction due to close in the next few months, Darmstadt, Germany-based pharmaceuticals and chemicals producer Merck KGaA has agreed to sell its DDS bioanalytics division to laboratory operator Eurofins Scientific for an undisclosed sum. All of the business's 175 employees are expected to transfer to Luxembourg-based Eurofins, which manufactures products for pharmaceutical research. DDS last reported annual sales of around €26 million.
Jens Birgersson becomes new Brenntag CEO
The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.
Valerie Diele-Braun resigned from her position as CEO and member of the Executive Board of IMCD at the end of April for personal reasons.
Honeywell will acquire Johnson Matthey's Catalyst Technologies business segment for €2.15 billion in an all-cash transaction.
Novo Nordisk recently announced changes to its executive leadership and Board of Directors.
